2 recruiting, 1 active not recruiting, 1 unknown. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Active not recruiting 1, Unknown 1 |
| Phase 2 | 3 | Recruiting 2, Unknown 1 |
Follow Forward Pharmaceuticals Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Food Effecton the Pharmacokinetics of FWD1802 in Healthy Subjects FWD1802 - Healthy | Phase 1 | Active not recruiting | Forward Pharmaceuticals Co., Ltd. | 18 | 2026-03-15 | 2026-07-16 |
| A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC FWD1802, Palbociclib 125mg, Ribociclib 200Mg Oral Tablet - Metastatic Breast Cancer, Breast Cancer Stage I | Phase 1 / Phase 2 | Recruiting | Forward Pharmaceuticals Co., Ltd. | 196 | 2025-06-01 | 2026-01-07 |
| A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC. FWD1802 - Metastatic Breast Cancer, Locally Advanced Breast Cancer | Phase 1 / Phase 2 | Recruiting | Forward Pharmaceuticals Co., Ltd. | 99 | 2023-09-12 | 2026-02-10 |
| A Study of FWD1509 in Adults With Non-Small Cell Lung Cancer FWD1509 MsOH - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Unknown | Forward Pharmaceuticals Co., Ltd. | 30 | 2021-08-23 | 2022-07-26 |
Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1)
Everolimus (1) · Tablets (1) · abemaciclib (1) · palbociclib (1) · ribociclib (1)
China (3) · United States (1)
Jian Zhang (1) · Yanmei Liu (1)